You are here

Industry News

Advamed Smart Brief

May 26, 2017
Illumina is planning to expand operations in China, its biggest market outside of the US, following double-digit growth in th -More
May 26, 2017
A private placement of 6.625 million units of common stock and stock purchase warrants could bring in $13.3 million for MRI I -More
May 26, 2017
Suwanee, Ga.-based Sanuwave Health has granted Lithomed a contract with a minimum order value of $500,000 to distribute its o -More
May 26, 2017
A Global Market Insights report predicts the worldwide market for orthopedic devices will reach $53 billion by 2024 because o -More
May 26, 2017
Medtronic saw 4.6% year-over-year revenue growth during its fiscal fourth quarter ending April 28, generating over $7.9 billi -More
May 26, 2017
A study of 545 women ages 25 to 50 years showed that the use of Provista Diagnostics' Videssa Breast assay in breast cancer d -More
May 26, 2017
The Prevena Duo incision management system has been launched by Acelity in the US.  -More
May 26, 2017
The FDA does not have to speed up its approval process for medical devices and instead should focus on ensuring the efficienc -More
May 26, 2017
The FDA has granted Bio-Rad Laboratories 510(k) clearance for enhanced options with its IH-Com patient results management sof -More
May 26, 2017
Japan's Pharmaceuticals and Medical Devices Agency has given Quidel approval for its Sofia Influenza A+B Fluorescent Immunoas -More

Industry News

RealClear Health
Often undiagnosed, an estimated two to six million people in the United States have a serious heart condition called atrial fibrillation, or AFib. As those living with the disease know, complications from the irregular heartbeat caused by the AFib can be potentially devastating: The average person with AFib is five times more likely to suffer a stroke than someone with a regular heartbeat. Fortunately, there is innovative medical technology available today poised to make a real difference in...
Legal Backgrounder
When a doctor implants a medical device, he or she often requests the presence of a representative of the device manufacturer (a “rep”) in the operating room. Some observers are critical of this practice, demanding thatreps be barred from the O.R. At the same time,some lawyersthink repsin the O.R.should be subject to liability in the court system. This Legal Backgrounder explains why reps often play an important, if limited, role in the O.R., and why that role should not expose reps to lawsuits
Business Wire
ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes. The round was led by Philips and UPMC, through its innovation and commercialization arm UPMC Enterprises, with other new and existing investors participating. The funding will support a planned US-based pivotal trial for...
Washington Examiner
Imagine for a moment that you are one of the approximately 44 million women in the U.S. affected by cardiovascular disease, or one of the 24 million with osteoarthritis. You'd want access to the most advanced and effective care. Oftentimes, your doctor would recommend a medical technology or device as an essential component of your treatment – placing a stent in a blocked artery or replacing your knee or hip with a new artificial one, for example. ​​​​​​
Fox Business
Mar. 09, 2017 - AdvaMed CEO Scott Whitaker discusses the impact of the medical device tax on business.​​​​​​